Imeglyn 500 Mg Tablet 10 - Uses, Side Effects, Dosage, Price

About Imeglyn 500 Tablet 10

Imeglyn 500 Tablet is used to manage type 2 diabetes mellitus. This medicine is part of a unique category of oral antidiabetic agents, known as glimins.

Apart from this main use, this tablet is also intended to correct the two core defects associated with type 2 diabetes insulin resistance and beta-cell failure. It provides a convenient way for those suffering from type 2 diabetes to manage their blood sugar levels when diet and exercise alone aren't enough.

You should take this medicine as directed by your doctor. It's essential to inform your doctor about any pre-existing conditions or ongoing medications before starting this tablet. If you observe any side effects while taking this medication, notify your doctor straight away. For the best results, it’s crucial to continue taking the medicine for the duration prescribed by your doctor.

Frequently Asked Questions (FAQs)

What is Imeglyn 500 Tablet used for?

Imeglyn 500 Tablet is used to manage type 2 diabetes in adults when diet and exercise alone are not sufficient.

How does this medicine work?

Imeglyn 500 Tablet helps to control blood sugar levels by improving insulin production and sensitivity, and by reducing glucose production in the liver.

How should I take Imeglyn 500 Tablet?

You should take Imeglyn 500 Tablet orally with meals. Remember, it should be swallowed whole and not crushed or chewed.

What are the possible side effects of this medication?

Potential side effects can include gastrointestinal issues like nausea and diarrhoea, headaches, urinary tract and genital infections.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it's nearly time for the next dose, skip the missed one.

Are there any precautions while taking Imeglyn 500 Tablet?

Avoid excessive alcohol intake while on this medication. It should be used with caution in elderly patients and those with renal or hepatic impairment.

Can I take this medicine during pregnancy or breastfeeding?

Imeglyn 500 Tablet is not recommended during pregnancy or breastfeeding due to insufficient safety data. Always consult your doctor for advice.

References

Huston, J., Schaffner, H., Langley, L., Skrable, B., Ashchi, A., Berner, J., Gore, A., Sheikh-Ali, M., Sutton, D., & Rebecca Goldfaden. (2022). Imeglimin in type 2 diabetes. In Drugs of Today (Vol. 9, pp. 437–449) [Journal-article]. https://doi.org/10.1358/dot.2022.58.9.3419555
Hallakou‐Bozec, S., Vial, G., Kergoat, M., Fouqueray, P., Bolze, S., Borel, A., Fontaine, E., & Moller, D. E. (2020). Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Diabetes Obesity and Metabolism, 23(3), 664–673. https://doi.org/10.1111/dom.14277
Dubourg, J., Fouqueray, P., Quinslot, D., Grouin, J., & Kaku, K. (2021). Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial. Diabetes Obesity and Metabolism, 24(4), 609–619. https://doi.org/10.1111/dom.14613
Vuylsteke, V., Chastain, L. M., Maggu, G. A., & Brown, C. (2015). Imeglimin: a potential new Multi-Target drug for Type 2 diabetes. Drugs in R&D, 15(3), 227–232. https://doi.org/10.1007/s40268-015-0099-3
Vinayagam, P., Senathipathi, V., Shivam, V., & Velraju, N. (2023). The role of Imeglimin in glycemic control, beta cell function and safety outcomes in patients with type 2 diabetes mellitus: A comprehensive meta-analysis. Diabetes Epidemiology and Management, 12, 100164. https://doi.org/10.1016/j.deman.2023.100164

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.